Trials / Terminated
TerminatedNCT02020499
Predictive Factors Study
Non-interventional, Observational, Long Term Study to Evaluate Common Therapeutic Algorithms and Possible Predictive Parameters for Somatuline Autogel (ATG) Treatment in Patients With Acromegaly.
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 5 (actual)
- Sponsor
- Ipsen · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a long term study to evaluate common therapeutic algorithms and possible predictive parameters for Somatuline Autogel treatment in patients with Acromegaly.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Somatuline Autogel® (lanreotide) 60, 90, 120 mg. | Patients receiving treatment as prescribed by the investigator and according to current treatment recommendations and routine clinical practice, and in line with local regulations. |
Timeline
- Start date
- 2014-08-01
- Primary completion
- 2015-09-01
- Completion
- 2015-09-01
- First posted
- 2013-12-25
- Last updated
- 2019-01-14
Locations
6 sites across 1 country: Australia
Source: ClinicalTrials.gov record NCT02020499. Inclusion in this directory is not an endorsement.